More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: The role of azathioprine

Experimental Dermatology

Volumn 17, Issue 4, 2008, Pages 349-355

  de Graaf, Ymke G L ^a   Rebel, Heggert ^a   Elghalbzouri, Abdoel ^a   Cramers, Patricia ^a   Nellen, Ruud G L ^a,b   Willemze, Rein ^a   Bouwes Bavinck, Jan Nico ^a   de Gruijl, Frank R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Azathioprine; DNA repair; P53 patches; Renal transplant recepients

Indexed keywords

AZATHIOPRINE; PROTEIN P53; PYRIMIDINE;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; GENE MUTATION; HAIRLESS MOUSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; KERATINOCYTE; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; RECIPIENT; RISK ASSESSMENT; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET IRRADIATION;

ADULT; AGED; ANIMALS; AZATHIOPRINE; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; DNA REPAIR; EPIDERMIS; FEMALE; GENES, P53; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; KIDNEY TRANSPLANTATION; MALE; MICE; MICE, INBRED HRS; MIDDLE AGED; MUTATION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 40349096481     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00651.x     Document Type: Article

References (37)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003: 348: 1681-1691.
2. London N J, Farmery S M, Will E J, Davison A M, Lodge J P. Risk of neoplasia in renal transplant patients. Lancet 1995: 346: 403-406.
3. Hartevelt M M, Bavinck J N, Kootte A M, Vermeer B J, Vandenbroucke J P. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990: 49: 506-509.
4. Bouwes Bavinck J N, Hardie D R, Green A et.al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996: 61: 715-721.
5. Brash D E, Rudolph J A, Simon J A et.al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991: 88: 10124-10128.
6. Ziegler A, Jonason A S, Leffell D J et.al. Sunburn and p53 in the onset of skin cancer [see comments]. Nature 1994: 372: 773-776.
7. Lisby S, Gniadecki R, Wulf H C. UV-induced DNA damage in human keratinocytes: Quantitation and correlation with long-term survival. Exp Dermatol 2005: 14: 349-355.
8. Berg R J, van Kranen H J, Rebel H G et.al. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: Immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci U S A 1996: 93: 274-278.
9. Jonason A S, Kunala S, Price G J et.al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A 1996: 93: 14025-14029.
10. Ren Z P, Ponten F, Nister M, Ponten J. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis. Int J Cancer 1996: 69: 174-179.
11. Rebel H, Mosnier L O, Berg R J et.al. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: Kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity. Cancer Res 2001: 61: 977-983.
12. Rebel H, Kram N, Westerman A, Banus S, van Kranen H J, de Gruijl F R. Relationship between UV-induced mutant p53 patches and skin tumours, analysed by mutation spectra and by induction kinetics in various DNA-repair-deficient mice. Carcinogenesis 2005: 26: 2123-2130.
13. Fisher M S, Kripke M L. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci U S A 1977: 74: 1688-1692.
14. Kripke M L. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974: 53: 1333-1336.
15. Fisher M S, Kripke M L. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 1982: 216: 1133-1134.
16. Kelly G E, Meikle W, Sheil A G. Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 1987: 44: 429-434.
17. Kelly G E, Meikle W, Sheil A G. Scheduled and unscheduled DNA synthesis in epidermal cells of hairless mice treated with immunosuppressive drugs and UVB-UVA irradiation. Br J Dermatol 1987: 117: 429-440.
18. Thoms K M, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007: 16: 532-544.
19. Ren Z P, Hedrum A, Ponten F et.al. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 1996: 12: 765-773.
20. El Ghalbzouri A, Hensbergen P, Gibbs S, Kempenaar J, van der S R, Ponec M. Fibroblasts facilitate re-epithelialization in wounded human skin equivalents. Lab Invest 2004: 84: 102-112.
21. Ponec M, Kempenaar J A, De Kloet E R. Corticoids and cultured human epidermal keratinocytes: Specific intracellular binding and clinical efficacy. J Invest Dermatol 1981: 76: 211-214.
22. van Zeeland A A, Smith C A, Hanawalt P C. Sensitive determination of pyrimidine dimers in DNA of UV-irradiated mammalian cells. Introduction of T4 endonuclease V into frozen and thawed cells. Mutat Res 1981: 82: 173-189.
23. Remenyik E, Wikonkal N M, Zhang W, Paliwal V, Brash D E. Antigen-specific immunity does not mediate acute regression of UVB-induced p53-mutant clones. Oncogene 2003: 22: 6369-6376.
24. Herman M, Weinstein T, Korzets A et.al. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med 2001: 137: 14-20.
25. Chan G L, Erdmann G R, Gruber S A, Matas A J, Canafax D M. Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol 1990: 30: 358-363.
26. Jans J, Schul W, Sert Y G et.al. Powerful skin cancer protection by a CPD-photolyase transgene. Curr Biol 2005: 15: 105-115.
27. Benjamin C L, Ananthaswamy H N. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2006: In press.
28. Ruven H J, Berg R J, Seelen C M et.al. Ultraviolet-induced cyclobutane pyrimidine dimers are selectively removed from transcriptionally active genes in the epidermis of the hairless mouse. Cancer Res 1993: 53: 1642-1645.
29. Tang J Y, Hwang B J, Ford J M, Hanawalt P C, Chu G. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol Cell 2000: 5: 737-744.
30. Alekseev S, Kool H, Rebel H et.al. Enhanced DDB2 expression protects mice from carcinogenic effects of chronic UV-B irradiation. Cancer Res 2005: 65: 10298-10306.
31. Kelly G E, Meikle W D, Moore D E. Enhancement of UV-induced skin carcinogenesis by azathioprine: Role of photochemical sensitisation. Photochem Photobiol 1989: 49: 59-65.
32. O'Donovan P, Perrett C M, Zhang X et.al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005: 309: 1871-1874.
33. McGregor JM, Berkhout RJ, Rozycka M et.al. p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene 1997: 15: 1737-1740.
34. Backvall H, Wolf O, Hermelin H, Weitzberg E, Ponten F. The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma. Br J Dermatol 2004: 150: 259-266.
35. Tabata H, Nagano T, Ray A J, Flanagan N, Birch-MacHin M A, Rees J L. Low frequency of genetic change in p53 immunopositive clones in human epidermis. J Invest Dermatol 1999: 113: 972-976.
36. Zhang W, Remenyik E, Zelterman D, Brash D E, Wikonkal N M. Escaping the stem cell compartment: Sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci U S A 2001: 98: 13948-13953.
37. Backvall H, Stromberg S, Gustafsson A et.al. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma. Exp Dermatol 2004: 13: 643-650.